A109S (p.Ala109Ser) variant of LBR (Delta(14)-sterol reductase LBR)
A109S (p.Ala109Ser) in LBR (Delta(14)-sterol reductase LBR) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.13 / 1. The record also includes structural context.
A109S (p.Ala109Ser) variant details
- p.Ala109Ser
- NCI-TCGA Cosmic COSV5528
- cosmic curated COSV55287
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.132
- REVEL 0.08
- ESM-1b 0.00
- AlphaMissense 0.07
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available